Key Market Indicator:
F&G: 43
25.079,45 NASDAQ · 48.467,50 DOW · 6.814,45 S&P · 4.312,99 Gold · 59,48 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
FI4000480454
Filter zurücksetzen
© PR Newswire
14.12.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin
Article
News Preview
Bioretec Ltd  Inside information 14 December 2025 at 5:45 p.m. EETTAMPERE, Finland, Dec. 14, 2025 /PRNewswire/ -- Bioretec Oy ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodeg...
Themefolio
Profiler
Peergroup
© PR Newswire
14.12.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin
Article
News Preview
Bioretec Ltd  Inside information 14 December 2025 at 5:45 p.m. EETTAMPERE, Finland, Dec. 14, 2025 /PRNewswire/ -- Bioretec Oy ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodeg...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design
Article
News Preview
Bioretec Ltd Company release 13 November 2025 at 8.30 a.m. EET TAMPERE, Finland, Nov. 13, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January–September 2025. The complete business review is attached to this release as a PDF file and available on the company...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
13.11.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design
Article
News Preview
Bioretec Ltd Company release 13 November 2025 at 8.30 a.m. EET TAMPERE, Finland, Nov. 13, 2025/PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January–September 2025. The complete business review is attached to this release as a PDF file and available on the company'...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
12.11.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec initiates change negotiations to enhance operational efficiency and competitiveness
Article
News Preview
Bioretec Ltd Inside information 12 November 2025 at 12.30 p.m. EET TAMPERE, Finland, Nov. 12, 2025 /PRNewswire/ -- Bioretec Ltd is initiating change negotiations in accordance with the Finnish Act on Co-operation within Undertakings. The aim of the negotiations is to streamline and reorganize oper...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec initiates change negotiations to enhance operational efficiency and competitiveness
Article
News Preview
Bioretec Ltd Inside information 12 November 2025 at 12.30 p.m. EET TAMPERE, Finland, Nov. 12, 2025 /PRNewswire/ -- Bioretec Ltd is initiating change negotiations in accordance with the Finnish Act on Co-operation within Undertakings. The aim of the negotiations is to streamline and reorganize oper...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Correction: Bioretec Ltd's Half-year report 2025
Article
News Preview
Bioretec Ltd  Company release 31 October 2025 at 8.30 a.m. EET TAMPERE, Finland, Oct. 31, 2025 /PRNewswire/ -- Bioretec announced on 27 October 2025 that it will adjust and restate its previously reported figures for H1/2025. The adjustment and restatement is related to the sales a...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Correction: Bioretec Ltd's Half-year report 2025
Article
News Preview
Bioretec Ltd  Company release 31 October 2025 at 8.30 a.m. EET TAMPERE, Finland, Oct. 31, 2025 /PRNewswire/ -- Bioretec announced on 27 October 2025 that it will adjust and restate its previously reported figures for H1/2025. The adjustment and restatement is related to the sales a...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025
Article
News Preview
Bioretec Ltd  Inside information 27 October 2025 at 9.14 p.m. EEST TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company"), announced through a press release a new sales and distribution agreement with Tri-State Biologics ("TSB"), enabling th...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025
Article
News Preview
Bioretec Ltd  Inside information 27 October 2025 at 9.14 p.m. EEST TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company"), announced through a press release a new sales and distribution agreement with Tri-State Biologics ("TSB"), enabling th...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US
Article
News Preview
TAMPERE, Finland, Oct. 1, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Transitional Pass-Through Payment (TPT) status for the company's RemeOs™ Screw LAG Solid, effective October 1, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US
Article
News Preview
TAMPERE, Finland, Oct. 1, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Transitional Pass-Through Payment (TPT) status for the company's RemeOs™ Screw LAG Solid, effective October 1, 2025....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
04.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board
Article
News Preview
Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced the appointment of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB). Dr. DiGiovanni is an internationally recognized foot and ankle surgeon wh...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board
Article
News Preview
Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced the appointment of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB). Dr. DiGiovanni is an internationally recognized foot and ankle surgeon wh...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth
Article
News Preview
TAMPERE, Finland, Sept. 2, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales Outside U.S. (OUS; Europe and Rest of the World) and member of the Management Team. Winters will spearhead Bioretec's international commercial strategy, advancing th...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth
Article
News Preview
TAMPERE, Finland, Sept. 2, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales Outside U.S. (OUS; Europe and Rest of the World) and member of the Management Team. Winters will spearhead Bioretec's international commercial strategy, advancing th...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer
Article
News Preview
TAMPERE, Finland, Aug. 27, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer (CEO) effective immediately. Van Hellenberg Hubar-Fisher has served as Bioretec's interim CEO since May 2025 and as a member of the company's Bo...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer
Article
News Preview
TAMPERE, Finland, Aug. 27, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer (CEO) effective immediately. Van Hellenberg Hubar-Fisher has served as Bioretec's interim CEO since May 2025 and as a member of the company's Bo...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue
Article
News Preview
TAMPERE, Finland, Aug. 14, 2025 /PRNewswire/ -- Bioretec Ltd  Company announcement 14 August 2025 at 8.00 am EEST This company announcement is a summary of Bioretec Ltd's half-year report for January–June 2025. The complete half-year report with tables is attached to this release as a pdf file and available at the company's web pages at https://...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue
Article
News Preview
TAMPERE, Finland, Aug. 14, 2025 /PRNewswire/ -- Bioretec Ltd  Company announcement 14 August 2025 at 8.00 am EEST This company announcement is a summary of Bioretec Ltd's half-year report for January–June 2025. The complete half-year report with tables is attached to this release as a pdf file and available at the company's web pages at https://...
Themefolio
Profiler
Peergroup
© PR Newswire
27.06.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue
Article
News Preview
TAMPERE, Finland, June 27, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 27 June 2025 at 8.00 am EEST As previously announced, Bioretec Ltd ("Bioretec" or the "Company") has completed a rights issue (the "Offering"), in which a total of 6,156,618 new shares of the Company were subscribed for. The new shares subscribed for in the Offerin...
Themefolio
Profiler
Peergroup
© PR Newswire
27.06.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue
Article
News Preview
TAMPERE, Finland, June 27, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 27 June 2025 at 8.00 am EEST As previously announced, Bioretec Ltd ("Bioretec" or the "Company") has completed a rights issue (the "Offering"), in which a total of 6,156,618 new shares of the Company were subscribed for. The new shares subscribed for in the Offerin...
Themefolio
Profiler
Peergroup
© PR Newswire
24.06.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Final results of Bioretec Ltd's successful rights issue
Article
News Preview
TAMPERE, Finland, June 24, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 24 June 2025 at 18:30 EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE, OR ANY OTHER JURISDICTION IN WHICH PUBLI...
Themefolio
Profiler
Peergroup
© PR Newswire
24.06.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Final results of Bioretec Ltd's successful rights issue
Article
News Preview
TAMPERE, Finland, June 24, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 24 June 2025 at 18:30 EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE, OR ANY OTHER JURISDICTION IN WHICH PUBLI...
Themefolio
Profiler
Peergroup
© PR Newswire
23.06.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Preliminary result of Bioretec Oy's rights issue
Article
News Preview
Bioretec Ltd Inside information 23 June 2025 at 12.30 EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE, OR ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. TAMPERE,...
Themefolio
Profiler
Peergroup
© PR Newswire
04.06.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd publishes an exemption document relating to its rights issue
Article
News Preview
Bioretec Ltd Company announcement 4 June 2025 at 4:00 p.m. EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE, OR ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. TAMP...
Themefolio
Profiler
Peergroup
© PR Newswire
28.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue
Article
News Preview
Bioretec Ltd  Inside information 28 May 2025 at 2.00 p.m. EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE, OR ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. TAMPE...
Themefolio
Profiler
Peergroup
© PR Newswire
20.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register
Article
News Preview
Bioretec Ltd Company announcement 20 May 2025 at 2.00 p.m. EEST TAMPERE, Finland, May 20, 2025 /PRNewswire/ -- An aggregate number of 60,000 new shares of Bioretec Ltd have been subscribed for with option rights under option program 2018-1A. The new shares have on 20 May 2025 been registered with the trade register maintained by the Finnish Paten...
Themefolio
Profiler
Peergroup
© PR Newswire
20.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register
Article
News Preview
Bioretec Ltd Company announcement 20 May 2025 at 2.00 p.m. EEST TAMPERE, Finland, May 20, 2025 /PRNewswire/ -- An aggregate number of 60,000 new shares of Bioretec Ltd have been subscribed for with option rights under option program 2018-1A. The new shares have on 20 May 2025 been registered with the trade register maintained by the Finnish Paten...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec
Article
News Preview
Bioretec Ltd  Inside information 15 May 2025 at 10.15 a.m. EEST TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- Bioretec's Board of Directors has appointed MBA Sarah van Hellenberg Hubar-Fisher as the company's interim CEO. Van Hellenberg Hubar-Fisher will take up her position effective immediately. Van Hellenberg Hubar-Fisher will continue as a...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec
Article
News Preview
Bioretec Ltd  Inside information 15 May 2025 at 10.15 a.m. EEST TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- Bioretec's Board of Directors has appointed MBA Sarah van Hellenberg Hubar-Fisher as the company's interim CEO. Van Hellenberg Hubar-Fisher will take up her position effective immediately. Van Hellenberg Hubar-Fisher will continue as a...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products
Article
News Preview
Bioretec Ltd  Company announcement 15 May 2025 at 8:00 a.m. TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-March 2025. The complete business review is attached to this release as a PDF file and available on the company's website at https://investors.bioretec.com/en/reports_an...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products
Article
News Preview
Bioretec Ltd  Company announcement 15 May 2025 at 8:00 a.m. TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-March 2025. The complete business review is attached to this release as a PDF file and available on the company's website at https://investors.bioretec.com/en/reports_an...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec´s CEO Alan Donze to resign
Article
News Preview
Bioretec Ltd    Inside information       8 May 2025 at 6:45 p.m. EET TAMPERE, Finland, May 8, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd announces that the company's CEO, Alan Donze, will resign from his position and will remain available for the company until July 7, 2025. The Board of Directors of Bioretec would like to thank...
Themefolio
Profiler
Peergroup
© PR Newswire
21.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Board of Directors has decided on a new option program for the CEO
Article
News Preview
Bioretec Ltd Company announcement 21st of March 2025 at 3:00 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd has on 21st of March 2025 resolved, on the basis of the authorization granted by the company's Annual General Meeting on 21st of March 2025, to establish a new option program as an incentive...
Themefolio
Profiler
Peergroup
© PR Newswire
21.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors
Article
News Preview
Bioretec Ltd Company announcement 21 March 2025 at 2:30 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 21 March 2025 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2024 and resolved to discharge the me...
Themefolio
Profiler
Peergroup
© PR Newswire
21.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Board of Directors has decided on a new option program for the CEO
Article
News Preview
Bioretec Ltd Company announcement 21st of March 2025 at 3:00 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd has on 21st of March 2025 resolved, on the basis of the authorization granted by the company's Annual General Meeting on 21st of March 2025, to establish a new option program as an incentive...
Themefolio
Profiler
Peergroup
© PR Newswire
21.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors
Article
News Preview
Bioretec Ltd Company announcement 21 March 2025 at 2:30 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 21 March 2025 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2024 and resolved to discharge the me...
Themefolio
Profiler
Peergroup
© PR Newswire
14.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)
Article
News Preview
Bioretec Ltd Company announcement 14 March 2025 at 7:30 p.m. EET TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has on 14 March 2025 received a notification in accordance with the Securities Market Act, according to which the holdings of shares and votes of W&M GmbH in Bioretec Ltd have on 14 March 2025 crossed the threshold of...
Themefolio
Profiler
Peergroup
© PR Newswire
14.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)
Article
News Preview
Bioretec Ltd Company announcement 14 March 2025 at 7:30 p.m. EET TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has on 14 March 2025 received a notification in accordance with the Securities Market Act, according to which the holdings of shares and votes of W&M GmbH in Bioretec Ltd have on 14 March 2025 crossed the threshold of...
Themefolio
Profiler
Peergroup
© PR Newswire
14.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Annual Report 2024 published
Article
News Preview
Bioretec Ltd    Press Release  14 March 2025 at 7:00 p.m. EET TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has today published its 2024 Annual Report. The Annual Report is attached to this release and also available in Finnish and English on the company's website at https://investors.bioretec.com/en/reports_and_presentations. Bio...
Themefolio
Profiler
Peergroup
© PR Newswire
14.03.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Annual Report 2024 published
Article
News Preview
Bioretec Ltd    Press Release  14 March 2025 at 7:00 p.m. EET TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has today published its 2024 Annual Report. The Annual Report is attached to this release and also available in Finnish and English on the company's website at https://investors.bioretec.com/en/reports_and_presentations. Bio...
Themefolio
Profiler
Peergroup
© PR Newswire
28.02.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
NOTICE OF ANNUAL GENERAL MEETING OF BIORETEC LTD
Article
News Preview
TAMPERE, Finland, Feb. 28, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 28 February at 12.30 p.m. EET  The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 21 March 2025 at 11:00 a.m. (Finnish time) at Bioretec premises in the auditorium of Tampark, at the address Yrittäjänkulma 5, FI-33710 Ta...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec
Article
News Preview
TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, has achieved a pivotal milestone with the successful completion of its CE mark approval process for the RemeOs™ Trauma Screw product portfolio. With the CE mark, Bioretec can immediately start selling products in Europe through the distribu...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec
Article
News Preview
TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, has achieved a pivotal milestone with the successful completion of its CE mark approval process for the RemeOs™ Trauma Screw product portfolio. With the CE mark, Bioretec can immediately start selling products in Europe through the distribu...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Financial Statements 2024 published
Article
News Preview
Bioretec Ltd    Company announcement      14 February 2025 at 5:00 p.m. EET TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd has today published its 2024 Financial Statements and Report by the Board of Directors. The publications are attached to this release and also available in Finnish and English on the company's website at www.bio...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's Financial Statements 2024 published
Article
News Preview
Bioretec Ltd    Company announcement      14 February 2025 at 5:00 p.m. EET TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd has today published its 2024 Financial Statements and Report by the Board of Directors. The publications are attached to this release and also available in Finnish and English on the company's website at www.bio...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth in 2024 - CE mark received in January 2025
Article
News Preview
TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd  Company announcement 14 February 2025 at 8:00 a.m. This company announcement is a summary of Bioretec Ltd's financial statements bulletin for January–December 2024. The complete financial statements bulletin with tables is attached to this release as a pdf file and available at the co...
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth in 2024 - CE mark received in January 2025
Article
News Preview
TAMPERE, Finland, Feb. 14, 2025 /PRNewswire/ -- Bioretec Ltd  Company announcement 14 February 2025 at 8:00 a.m. This company announcement is a summary of Bioretec Ltd's financial statements bulletin for January–December 2024. The complete financial statements bulletin with tables is attached to this release as a pdf file and available at the co...
Themefolio
Profiler
Peergroup
© PR Newswire
31.01.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe
Article
News Preview
TAMPERE, Finland, Jan. 31, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, has successfully completed its CE mark approval process and can start commercialization of its RemeOs™ Trauma Screw product portfolio within the European Union and non-European countries that recognize the CE mark market authorization. This...
Themefolio
Profiler
Peergroup
© PR Newswire
31.01.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe
Article
News Preview
TAMPERE, Finland, Jan. 31, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, has successfully completed its CE mark approval process and can start commercialization of its RemeOs™ Trauma Screw product portfolio within the European Union and non-European countries that recognize the CE mark market authorization. This...
Themefolio
Profiler
Peergroup
© PR Newswire
22.11.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market
Article
News Preview
Bioretec Ltd Press release 22 November 2024 at 9:30 a.m.EET TAMPERE, Finland, Nov. 22, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of the commercialization of its innovative RemeOs™ Trauma Products in the U.S. market. As a continuation to the...
Themefolio
Profiler
Peergroup
© PR Newswire
22.11.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market
Article
News Preview
Bioretec Ltd Press release 22 November 2024 at 9:30 a.m.EET TAMPERE, Finland, Nov. 22, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of the commercialization of its innovative RemeOs™ Trauma Products in the U.S. market. As a continuation to the...
Themefolio
Profiler
Peergroup
© PR Newswire
20.11.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement
Article
News Preview
Bioretec Ltd Press release 20 November 2024 at 3:30 p.m. EET TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of commercializing its innovative RemeOs™ Trauma Products in the U.S. market. Bioretec strengthens its operati...
Themefolio
Profiler
Peergroup
© PR Newswire
20.11.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement
Article
News Preview
Bioretec Ltd Press release 20 November 2024 at 3:30 p.m. EET TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of commercializing its innovative RemeOs™ Trauma Products in the U.S. market. Bioretec strengthens its operati...
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's business review January-September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage
Article
News Preview
Bioretec Ltd  Company announcement 14 November 2024 at 8:45 a.m. TAMPERE, Finland, Nov. 14, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-September 2024. The complete business review is attached to this release as a PDF file and available on the company's website at https://bioretec.com/investors/inv...
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Ltd's business review January-September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage
Article
News Preview
Bioretec Ltd  Company announcement 14 November 2024 at 8:45 a.m. TAMPERE, Finland, Nov. 14, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-September 2024. The complete business review is attached to this release as a PDF file and available on the company's website at https://bioretec.com/investors/inv...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage
Article
News Preview
TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec updates its product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage, an innovative medical device engineered from a multifunctional, MRI-compatible, absorbable hybrid composite based on the company's proprietary magnesium alloy. The decision...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage
Article
News Preview
TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec updates its product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage, an innovative medical device engineered from a multifunctional, MRI-compatible, absorbable hybrid composite based on the company's proprietary magnesium alloy. The decision...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2024
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Inside information: Bioretec updates its financial targets
Article
News Preview
Bioretec Ltd  Company announcement 4 October 2024 at 2:31 p.m. EEST TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec Ltd announced today, 4 October 2024, that Bioretec's board of directors had decided to update the company's product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage following...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 16.12.2025, Calendar Week 51, 350th day of the year, 15 days remaining until EoY.